drugset / Trial / NCT05583604

Managed Access Programs for AIN457, Secukinumab

NCT05583604

Expanded access Available Novartis Pharmaceuticals

Summary

The purpose of this registration is to list Managed Access Programs (MAPs) related to AIN457, secukinumab

Timeline

Start
Primary completion
Completion

Drugs

EvaluationDrugModalityDoseRoute
Background Secukinumab Monoclonal antibody